GAPDH and Alzheimer disease: It has been hypothesized that the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), one of the most abundant cellular proteins, may have a role in AD pathogenesis [8,9], possibly due to the formation of neurotoxic aggregates with Aβ [10,11].